Australia Stock Exchange release from CHIMERIC THERAPE : CDH17 CAR T PRECLINICAL DATA FEATURED IN NATURE CANCER
23/03/2022 03:04
Australia Stock Exchange release from CHIMERIC THERAPE CHM.AX : CDH17 CAR T PRECLINICAL DATA FEATURED IN NATURE CANCER
Recent news on Chimeric Therapeutics
See all newsBrief: Chimeric Therapeutics Says Phillip Hains Appointed Interim Chairman
Brief: Chimeric Therapeutics Posts Prelim Loss For Year Of A$18.8 MLN
Brief: Chimeric Therapeutics Intends To Enter Negotiations With Its Creditors
Brief: Chimeric Therapeutics Seeks Trading Halt
Australia's Chimeric Therapeutics rises on positive data for its cell therapy clinical trial